Over the course of more than a century of laboratory experimentation, Bacillus subtilis has become "domesticated," losing its ability to carry out many behaviors characteristic of its wild ancestors. One such characteristic is the ability to form architecturally complex communities, referred to as biofilms. Previous work has shown that the laboratory strain 168 forms markedly attenuated biofilms compared with the wild strain NCIB3610 (3610), even after repair of a mutation in sfp (a gene involved in surfactin production) previously known to impair biofilm formation. Here, we show that in addition to the sfp mutation, mutations in epsC, swrA, and degQ are necessary and sufficient to explain the inability of the laboratory strain to produce robust biofilms. Finally, we show that the architecture of the biofilm is markedly influenced by a large plasmid present in 3610 but not 168 and that the effect of the plasmid can be attributed to a gene we designate rapP. When rapP is introduced into 168 together with wild-type alleles of sfp, epsC, swrA, and degQ, the resulting repaired laboratory strain forms biofilms that are as robust as and essentially indistinguishable in architecture from those of the wild strain, 3610. Thus, domestication of B. subtilis involved the accumulation of four mutations and the loss of a plasmid-borne gene.
The soil-dwelling bacterium Bacillus subtilis has been studied in the laboratory for well over a century. During this time, manipulation in the laboratory has domesticated B. subtilis, introducing mutations that have altered several of its characteristic behaviors. Whereas undomesticated strains have the capacity to swarm on surfaces and form complex structured communities (biofilms), many laboratory strains fail to swarm and form smooth colonies and thin pellicles at the surface of liquids (5, 15) . Here we sought to identify the full set of mutations common in laboratory strains that account for their inability to form robust biofilms.
Although Christian Gottfried Ehrenberg (12) is often credited with the first published description of B. subtilis, the first authoritative description of Bacillus subtilis was in 1877 by Ferdinand Cohn, who isolated the bacterium after briefly boiling a culture in which hay had soaked for several hours (9) . Cohn likely did not use pure cultures of this bacterium, but he described many of the hallmark features of B. subtilis: the transition between motile and filamentous cells, the development of spores, and the formation of a floating pellicle biofilm on a static liquid culture. The term "biofilm" was coined much later; nonetheless, Cohn clearly describes pellicle formation: "…the development after about 2 days of a delicate, iridescent film on the surface of the liquid. Soon thereafter the top layer began to become turbid and assume a slimy-flocculent or scaly character" (translated in reference 6).
Cohn's work unequivocally defined the characteristics of B. subtilis. However, the ancestor of most common laboratory strains was not isolated until around 1899 at the University of Marburg (by Meyer and Gottheil, as described in reference 10). In 1930, H. J. Conn systematically tested a dozen strains and defined the B. subtilis type as this Marburg strain, defined by the cell and spore size, germination pattern, and the formation of "slightly wrinkled" colonies that stuck tightly to the agar (10) . Although the culture conditions and medium differed from those used today, the colony and pellicle descriptions from these seminal works by Cohn and Conn suggest that their B. subtilis strains formed biofilms and more closely resemble the "wild" strains of NCIB3610 (3610) and ATCC 6051 than the more commonly used modern laboratory strains 168, PY79, and JH642. (It is important to note that not all strains designated "168" are the same. Here we tested the biofilmforming capacities of 168 strains from the collections of R. Losick, R. Kolter, and A. L. Sonenshein. These included four 168 strains as well as derivatives of 168 designated PY79, JH642, and 168 BFA. All were markedly impaired in biofilm formation, except for 168 BFA, for reasons explained herein.)
At least some of the mutations that domesticated B. subtilis were likely introduced by Burkholder and Giles prior to their experimentation to irradiate the bacterium with UV light or X rays to study amino acid synthesis and metabolism (7, 25) . In 1958, Spizizen demonstrated that the four surviving auxotrophic strains mutated during the course of their work were competent to import and integrate genetic material from the environment, making genetic manipulations much easier (22) . As a result of this work, strain 168 became the primary laboratory strain for B. subtilis research worldwide.
The ability of B. subtilis to form robust biofilms was not described until 2001 by Branda et al. (4) , who were working with strain 3610, which is closely related to the ancestor of 168 (25) . Strains 168 and 3610 are similar on a genomic level, suggesting that a small number of mutations are responsible for their phenotypic differences (11) . One such mutation that impairs biofilm formation is in sfp, a gene required for the production of surfactin (17, 20) . We now know that surfactin is both a surfactant required for surface motility and a signaling molecule for biofilm formation (15, 17) . However, laboratory strains corrected for the sfp mutation remain impaired in biofilm formation, indicating the presence of additional unknown genetic lesions that prevent the formation of architecturally complex communities. Here, we describe three additional mutations present in strain 168 but not 3610 that contribute to the loss of robust biofilm formation: (i) a previously undescribed mutation in the exopolysaccharide production gene epsC; (ii) a mutation in regulatory gene swrA for the fla/che operon, which was not previously known to play a role in biofilm formation; and (iii) a promoter mutation for the regulatory gene degQ, which facilitates the transfer of an activating phosphate from degS to degU and leads to the secretion of degradative enzymes, such as amylases and proteases (16, 24) . In addition, we show that biofilm architecture is strongly influenced by the presence of a plasmid in 3610 that is absent in 168 and that the effect of the plasmid can be largely attributed to a particular plasmid-borne gene, rapP. Introduction of rapP into 168 and correction of the four mutations restored biofilm robustness essentially to that of the wild parent.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The B. subtilis strains used in this study are listed in Table 1 . Escherichia coli strain DH5␣ was used for construction and maintenance of plasmids. Strains were grown in LB medium (10 g/liter tryptone, 5 g/liter yeast extract, 5 g/liter NaCl), TY medium (LB with the addition of 10 mM MgSO 4 and 100 M MnSO 4 ), or MSgg medium (5 mM potassium phosphate, 100 mM morpholinepropanesulfonic acid, pH 7 [MOPS], 2 mM MgCl 2 , 50 M MnCl 2 , 50 M FeCl 3 , 700 M CaCl 2 , 1 M ZnCl 2 , 2 M thiamine, 0.5% glycerol, 0.5% glutamate, 50 g/ml threonine, tryptophan, and phenylalanine). Solid medium contained 1.5% Bacto agar. Pellicle biofilms were grown in 6-well microtiter plates in 10 ml liquid MSgg medium inoculated with 10 l of an LB starter culture and were incubated for 3 days at 30°C. Colony biofilms were inoculated with 3 l liquid starter culture, allowed to dry, and grown at 30°C for 3 days on solid MSgg plates. Antibiotics and supplements were included as appropriate at the following concentrations: ampicillin (100 g/ml), spectinomycin (100 g/ml), tetracycline (10 g/ml), chloramphenicol (5 g/ml), erythromycin (0.5 g/ml) and lincomycin (2.5 g/ml), kanamycin (5 g/ml), and X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside; 100 g/ml).
Congression and transformation. Transformation into B. subtilis was carried out as previously described (3) . Congression transformation reactions were carried out as described previously (23) , but cells were incubated with DNA for 2 h before plating. When being tested for linkage or to identify congressants with biofilm phenotypes, cells were plated on MSgg agar containing appropriate antibiotics and, where appropriate, X-Gal (100 g/ml) and were incubated for 2 days at 37°C. Images of plates were captured with a Nikon Coolpix camera.
Markerless allele switching in epsC. We amplified a 1-kb-long stretch of DNA centered around the C ⅐ G base pair at position 827 in epsC using primers described in Table 2 , cloned it into the pMAD switching plasmid, and integrated it into our recipient strain by a single crossover recombination (2) . We then screened for derivatives of the integration strain that had spontaneously lost the plasmid by recombinational excision.
Transposon integration. To create a transposon library of PY79 and AM297, cells were transformed with the mini-Tn10-containing plasmid pIC333 and plated on solid LB medium with macrolides-lincosamide-streptogramin B (MLS) and incubated for 2 days at 22°C, or until colonies appeared. Five transformants of PY79 and three of AM297 were colony purified and used to inoculate separate overnight LB cultures containing spectinomycin. The overnight cultures were diluted 1:100 into LB medium containing spectinomycin and grown at room temperature for 3 h before being shifted to 37°C for 4 h. Aliquots of each culture were plated on 2 LB-spectinomycin plates and grown overnight at 37°C. Cells were harvested in parallel from each plate, and genomic DNA was isolated and used for mapping by transformation following standard protocols. To maximize the diversity of transposon insertions, we conducted parallel transformation reactions with two separate DNA preparations from each of the 5 independent PY79 libraries and the 3 independent AM297 libraries.
EPS precipitation. Extracellular polysaccharide (EPS) precipitation and visualization were carried out as described previously (13). Illumina whole-genome sequencing and analysis. Genomic DNA was isolated from strains AM311 and AM312 and sheared by sonication using a Bioruptor (Diagenode). An Illumina library was prepared using the genome sample preparation kit (Illumina), concentrations were measured by quantitative PCR (qPCR), and the library was sequenced by 36-bp single end reads on an Illumina genome analyzer II through the Harvard Center for Systems Biology core facility. The data were aligned to the 168 reference genome (NC_000964.2) and sorted using Bowtie and pileup on Galaxy and an in-house script. Analysis was also done using CLC Bio Genome workbench for comparison. Possible mutations were validated by PCR and Sanger sequencing using the primers shown in Table 2 .
rapP complementation construct. To generate the P rapP -rapP phrP complementation construct (pDP105), a PCR product containing the rapP phrP coding region plus ϳ500 bp of upstream sequence was amplified from B. subtilis 3610 DNA with the primer pair 349/350 and digested with BamHI and EcoRV. The destination vector pDG364, containing a polylinker and chloramphenicol resistance cassette between two arms of the amyE gene (12a) was first digested with EcoRI and blunt ended by treatment with DNA polymerase I Klenow fragment (New England BioLabs). The linearized DNA was purified by phenol-chloroform extraction and ethanol precipitation and digested with BamHI. The digested DNA fragment containing rapP phrP was then ligated into the BamHI site on one end and a blunt end on the other of the digested pDP364 backbone to generate pDP105.
RESULTS AND DISCUSSION
A mutation that contributes to impaired biofilm formation. Laboratory strains of B. subtilis, such as 168, are often markedly attenuated in their ability to form robust biofilms compared to wild strains, such as 3610 (5) . A known mutation that contributes to impaired biofilm formation by 168 is in the sfp gene. sfp encodes a broad-substrate-specificity phosphopantetheinyl transferase involved in the production of numerous B. subtilis secondary metabolites (18) . Among these is surfactin, a lipopeptide signaling molecule known to help trigger the expression of genes involved in biofilm formation (17, 20) . Accordingly, the starting point for the present investigation was a derivative of 168 (RL3090) that was corrected for the sfp mutation. As shown in Fig. 1 , strain 168 itself formed flat, featureless colonies and a flat, thin pellicle, and correction of the sfp mutation (RL3090) yielded minimal changes in morphology ( Fig. 1 ; sfp ϩ ). In comparison, 3610 formed an architecturally complex colony on solid biofilm-inducing medium (MSgg) and a thick and structurally complex pellicle at the air-liquid interface of a standing culture grown in MSgg.
To identify additional mutations in RL3090 responsible for defective biofilm formation, we used congression to move random segments of DNA from a strain of 3610 resistant to kanamycin and harboring a lacZ fusion (AM52) into competent cells of RL3090. Colonies from congressants showing an enhanced wrinkly morphology were visible after 2 days of incubation at 37°C (pink arrows in Fig. 2A ) and at a frequency of about 3 to 5%. As a control, no such colonies were observed among congressants generated with donor DNA from a domesticated strain harboring the kanamycin resistance gene and a lacZ fusion (Fig. 2B) . The more wrinkly colonies appeared at roughly the same frequency as blue colonies arising from uptake of the lacZ reporter, which appeared at a frequency of 1 to 5%. This observation is consistent with the idea that the enhanced wrinkly phenotype of each congressant resulted from correction of a single mutation or several closely linked mutations. Congressants that produced wrinkly colonies retained other characteristics of the recipient RL3090 strain; they were sensitive to chloramphenicol, LacZ Ϫ , and auxotrophic for tryptophan. The colonies and pellicles produced by the congressants exhibited a morphology that was intermediate between that of the recipient strain and that of the donor 3610 strain. That is, the congressants were only partially repaired in their ability to form biofilms, an observation that suggested that mutations at different loci were responsible for the defective biofilm phenotype of the laboratory strain. A mutation impairing biofilm formation is located in epsC. To identify the mutation that had been corrected in generating the wrinkly congressants, one such congressant (AM128) was colony purified and used to create competent cells. The competent cells were transformed with genomic DNA from a library of transposon Tn10 insertions into the genome of strain PY79 (a derivative of 168). Next, we screened the transformants for those exhibiting the impaired biofilm formation phenotype of the donor strain. We then prepared chromosomal DNA from 56 such transformants and in each case verified linkage to the mutation causing impaired biofilm formation to the transposon by transformation. observed measurable linkage, with cotransformation frequencies ranging from 6 to 30%. Finally, the location of each of the linked transposons was determined by sequencing DNA flanking chromosomal DNA. As can be seen in Fig. 3A , the transposons were clustered on either side of the epsA to -O (epsA-O) operon (triangles in Fig. 3A) , suggesting that the mutation(s) was located within the operon. That the mutation was in or near the operon was verified in transformation experiments using chromosomal DNA from strains of 3610 harboring antibiotic resistance cassettes that had been inserted into genes pnbA and sigL located near the eps operon (black bars in Fig. 3A) . Both markers showed approximately 35% linkage to the mutation responsible for the rough phenotype. Since the markers flank the epsA-O operon, this again suggested that the mutation was located within the epsA-O operon.
Sequence analysis of the epsA-O operon from RL3090 and from the AM128 congressant that had been partially repaired for biofilm formation revealed a single base pair difference. This was a C ⅐ G-to-T ⅐ A transition at bp 827 of epsC, which changed valine codon 276 (GCG) present in RL3090 to an alanine codon (GTG). Further sequence analysis confirmed that the original donor strain, 3610, had the alanine codon and that two other laboratory strains, JH642 and PY79 (which are derivatives of 168), had the valine codon. Thus, some laboratory strains harbor a mutation in epsC [epsC(A276V)], which we will refer to as epsC 168 . We were surprised to discover that the published genome sequence for 168 has the wild-type T ⅐ A base pair, which we confirmed by resequencing this region of the chromosome from the strain that had been used in generating the Subtilist database, which we will designate as strain 168 BFA (Fig. 3A) . However, when grown under biofilm conditions, 168 BFA produced more robust pellicles and more wrinkly colonies than did the other laboratory strains used in this study (data not shown). These findings confirm that the presence of a T ⅐ A at bp 827 is closely correlated with an increase in biofilm robustness. We acquired several other 168 strains, and only this 168 BFA strain contained the T ⅐ A at bp 827. Thus, we suggest that 168 strain variants that contain a repaired epsC allele should be so designated, similar to standard discussion of strains in which the tryptophan auxotrophy has been repaired. To rule out the possibility that the effect on biofilm robustness was actually due to an unknown, unlinked mutation and to produce a marker-free version of this strain, we switched the T ⅐ A base pair to a C ⅐ G base pair to repair epsC in RL3090, our original donor strain (see Materials and Methods). This newly built strain, AM271 (Fig. 1) , had the same biofilm phenotype as that observed in our congressant strain.
The epsC 168 mutation causes decreased exopolysaccharide production. The epsC gene is thought to play a role in exopolysaccharide synthesis, but its precise function is unknown. Sequence analysis using the SMART protein domain database suggests that EpsC contains two transmembrane segments and a large catalytic domain that resembles an epimerase or dehydrogenase. The alanine-to-valine substitution identified in certain laboratory strains lies near the N-terminal end of the catalytic domain (Fig. 3B) . The region containing the substitution is highly conserved, with an alanine or a glycine being found at the homologous position in orthologs from other species, such as Pseudomonas aeruginosa and Staphylococcus aureus (Fig. 3B) . It is likely that the bulky side chain of valine is responsible for impairing or altering the function of EpsC, and we hypothesized that the loss of this catalytic activity prevented proper exopolysaccharide synthesis.
To investigate this possibility, we created otherwise isogenic strains with the wild-type or mutant alleles of epsC in two different domesticated backgrounds (those of 168 and PY79) and in the wild 3610 background. We introduced mutations in sinR and tasA to increase overall exopolysaccharide production and to allow the release of that exopolysaccharide into the medium (4, 8) . Exopolysaccharide was first detected by the formation of aggregates following ethanol precipitation of cell supernatants. For each strain with the epsC 168 mutant allele, no exopolysaccharide aggregates were detected, whereas strains with the wild-type allele of epsC (epsC 3610 ) were able to produce such aggregates (Fig. 4) . Additionally, when the precipitate was resolved by SDS-PAGE, only strains with the wild-type allele of epsC showed an exopolysaccharide band (Fig. 4) . For comparison, an epsH mutant was also found to be defective in exopolysaccharide production (Fig. 4) (5, 13 ).
An additional mutation contributing to impaired biofilm formation. Although the derivative of RL3090 harboring the wild-type allele of epsC formed more robust biofilms than did the original recipient strain, the biofilms formed by this 168 sfp ϩ epsC ϩ strain were still attenuated in comparison with those of 3610. To identify other mutations responsible for the loss of biofilm robustness in domesticated strains, we used AM271 (168 sfp ϩ epsC ϩ ) as a recipient strain for a second round of congression with donor DNA from 3610. Once again, we were successful in identifying congressants that formed more robust biofilms than did the AM271 recipient. We introduced random insertions of Tn10 into one such congressant and obtained a Tn10 insertion that showed 60% cotransformation with a locus that caused a significantly rougher colony phenotype.
The third mutation contributing to impaired biofilm formation is located in swrA. Sequence analysis revealed the transposon was inserted in yvjA (Fig. 5A) . Independent confirmation that the mutation was located in the yvjA region came from transformation experiments using a marker (spec) that had been placed between the nearby genes yvyD and yvzG. The marker showedϳ50% linkage to the additional biofilm-impairing mutation, and transformation of AM271 with genomic DNA from a 3610 strain containing this marker resulted in many colonies forming more robust biofilms. One such strain, AM311, is shown in Fig. 1 . This region of the genome (Fig. 5A) contains swrA, which is known to be mutated in many laboratory strains (14) . The wild-type coding sequence contains an 8-bp track of A ⅐ T base pairs; laboratory strains typically contain an insertion of 1 bp, resulting in a frameshift mutation and a truncated, inactive protein. The wild-type SwrA protein stimulates transcription of the fla/che operon and is known to be needed for swarming motility and for poly-␥-polyglutamic acid synthesis (14, 23) . It therefore seemed attractive to suppose that the swrA mutation in laboratory strains contributes to impaired biofilm formation and that AM311 had been corrected for the swrA mutation. Sequence analysis confirmed that transformants that formed more robust biofilms contained the wild-type (8 A ⅐ T base pairs) allele of swrA and the less robust biofilm formers contained the mutant allele of swrA (Fig. 5A ). Sequence analysis of 7 kb of DNA in the region revealed no other mutations. Moreover, introduction of an insertion/deletion allele of swrA impaired the biofilm phenotype of AM311. We conclude that a strain carrying wild-type alleles of sfp, epsC, and swrA is more robust in biofilm formation than a corresponding strain that is mutant for swrA and hence that swrA also contributes to robust biofilm formation. Despite its known role in swarming and poly-␥-polyglutamic acid production and colony mucoidy (14, 23) , why was swrA not implicated in biofilm formation previously? We found that the introduction of a swrA mutation into 3610 caused only a subtle, easily overlooked effect on biofilm architecture. We therefore regard AM271 (sfp ϩ epsC ϩ ) as a sensitized strain in which the contribution of swrA was more readily apparent than in a fully robust, biofilm-forming strain.
A fourth mutation impairing biofilm formation is located in the promoter for degQ. Since our triply corrected laboratory strain AM311 (sfp ϩ epsC ϩ swrA ϩ ) was still not as robust in biofilm formation as is the wild strain 3610, we sought to identify further biofilm-attenuating mutations in the domesticated background. Another strain isolated during the same congression and transformation experiment as AM311 demonstrated more robust biofilm formation (Fig. 1) , and we anticipated that this strain, AM312, contained the wild, repaired allele of an additional biofilm-impairing mutation in addition to being swrA ϩ . Colonies with this phenotype appeared at a frequency of ϳ5% during the transformation reactions from which AM311 were isolated. Efforts to map the mutation by linkage to a Tn10 insertion were unsuccessful. We therefore turned to whole-genome sequencing to identify differences between AM311 and AM312 (see Materials and Methods). We identified seven point mutations that differed between the strains (Table 3) . We then directly sequenced the regions containing these changes in the parental 3610 and 168 strains and also from 5 independently generated congressant strains showing the same biofilm morphologies as AM311 and 5 indepen- identified by whole-genome sequencing dently generated hybrid strains showing the same morphologies as AM312. Only one of the mutations-the one near the regulatory gene degQ-met the criteria of being present in 168, AM311, and other congressants with impaired biofilm formation but absent in 3610, AM312, and independently isolated congressant strains with the more robust biofilm phenotype. Consistent with the assignment of the degQ mutation as being responsible for impaired biofilm formation in the tested strains, DNA-mediated transformation using a marker inserted in the chromosome in a gene (yueE) located near degQ revealed high linkage (55% cotransformation) between the marker and the mutation impairing biofilm formation (Fig. 5B) . Gratifyingly, Kobayashi (16) had previously and independently found that mutations in degQ impair biofilm formation. Sequence analysis revealed that the mutation was a T ⅐ Ato-C ⅐ G transition at the upstream (5Ј) end of the Ϫ10 region of the promoter for degQ. The wild-type T ⅐ A base pair at this position is highly conserved in promoters recognized by RNA polymerase containing A (19) . Indeed, during the initial characterization of degQ, Yang et al. observed that a mutant bearing this T ⅐ A base pair produced more DegQ (then called SacQ) activity, as judged by increased levels of secreted amylases, proteases, and levansucrase (1, 24) . Finally, we note that a degQ null mutation has been shown to impair poly-␥-polyglutamic acid synthesis in certain wild strains, which causes a mucoid colony phenotype (16, 23) . Poly-␥-polyglutamic acid, however, is not a component of the matrix, and its production is not required for robust biofilm formation (4) .
A plasmid-borne gene influences biofilm morphology. It is known that 3610 contains an 80-kb plasmid. In other work, one of us (D.B.K.) generated a derivative of 3610 that was cured of the plasmid (unpublished results). Interestingly, the cured strain exhibited a colony morphology phenotype that was highly similar to that of strain AM312, the strain that had been corrected for sfp, epsC, swrA, and degQ. Thus, it seemed possible that the only remaining, relevant difference between AM312 and 3610 was the absence of the plasmid in the corrected laboratory strain.
In an earlier screen for mutations altering matrix gene expression in 3610 by transposon-mediated insertional mutagenesis, we had in fact identified an insertion in a plasmid-borne gene. We designate this gene rapP because of the similarity of its inferred product to other members of the family of response regulator aspartate phosphatases from B. subtilis (21) . To investigate whether the absence of rapP in the corrected laboratory strain could account for the difference in morphology from 3610, we introduced DNA containing rapP (and the adjacent downstream gene phrP) at amyE in AM312. Strikingly, the resulting strain (AM373) formed colonies on biofilm-inducing medium that were essentially indistinguishable in architecture from those of 3610 (Fig. 1) .
In toto, the domestication of B. subtilis with respect to biofilm formation can be largely, if not entirely, attributed to five genetic alterations. These are point mutations in the coding sequences of sfp, epsC, and swrA; a promoter mutation in degQ; and the absence of the plasmid-borne gene rapP.
This has been in part an historical investigation in which we have sought to identify mutations that have accumulated over time in the domestication of a laboratory bacterium. It is difficult to know precisely when, and in which order, the mutations arose. For instance, did the epsC mutation arise in the laboratory of Burkholder and Giles, or did subsequent investigators inadvertently (or conceivably purposefully) select for decreased biofilm robustness by choosing smoother, more-reproducible-looking colonies? In any event, the lesson here is that generations of investigators have robbed laboratory strains of some of the important biological properties of the ancestral strains first studied by Meyer and Gottheil over a century ago and first described by Ehrenberg and Cohn a century and a half ago (10) .
